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Abstract Curcumin, the active ingredient of the rhizome of
Curcuma longa has anti-inflammatory, antioxidant and anti-
proliferative activities. Although its precise mode of action
remains elusive, studies have shown that chemopreventive action
of curcumin might be due to its ability to induce apoptosis in
cancer cells. Curcumin was shown to be responsible for the
inhibition of AK-5 tumor (a rat histiocytoma) growth by inducing
apoptosis in AK-5 tumor cells via caspase activation. This study
was designed to investigate the mechanism leading to the
induction of apoptosis in AK-5 tumor cells. Curcumin treatment
resulted in the hyperproduction of reactive oxygen species
(ROS), loss of mitochondrial membrane potential (vim) and
cytochrome c release to the cytosol, with the concomitant
exposure of phosphatidylserine (PS) residues on the cell surface.
This study suggests redox signalling and caspase activation as
the mechanisms responsible for the induction of curcumin
mediated apoptosis in AK-5 tumor cells.
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1. Introduction
Turmeric (Curcuma longa), a common Indian dietary pig-
ment and spice has been shown to possess a wide range of
therapeutic utilities in the traditional Indian medicine [1]. Its
role in wound healing, urinary tract disease, liver ailments,
hepatitis, are well documented in addition to its use as a
cosmetic [2,3]. The active component of turmeric, identi¢ed
as curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)1,6-hepta-
diene-3,5-dione] exhibits a variety of pharmacological e¡ects
including anti-in£ammatory, anticarcinogenic and anti-infec-
tious activities [2,4,5]. As a known antioxidant, curcumin also
exhibits antiproliferative capability and is thus identi¢ed as a
potent tool in cancer therapy [6^8]. The tumoricidal activity of
curcumin has been observed in a wide range of cell lines like
NIH3T3, mouse sarcoma S180, human kidney cancer cell 293
[9], Chinese hamster ovary [2] and human basal cell carcinoma
[6]. Studies have shown that dietary administration of curcu-
min signi¢cantly suppressed development of chemically in-
duced tumors in mice [10]. Its chemopreventive activity is
observed when it is administered during the promotion/pro-
gression stages of colon cancer [7].
A recent study from our laboratory demonstrated antitu-
mor activity of curcumin when it was injected intraperito-
neally in rats bearing the AK-5 tumor [11]. The antitumor
activity of curcumin was attributed to its ability to induce
apoptosis in AK-5 cells, via the activation of caspase-3. The
present study implicates reactive oxygen species as the key
apoptotic signalling molecules in AK-5 cells leading to the
loss of mitochondrial membrane potential, PS externalization
and release of apoptogenic proteins like cytochrome c.
2. Materials and methods
2.1. Materials
AK-5 tumor was maintained as ascites in an inbred colony of Wis-
tar rats by injecting 5U106 tumor cells i.p. We also used a single cell
clone of AK-5 called BC-8 in these studies to avoid ambiguity in
results due to tumor heterogeneity [12]. Dulbecco’s modi¢ed Eagle’s
medium (DMEM), FCS, curcumin, cytochrome c (type VI), super-
oxide dismutase (SOD), N-acetyl-L-cysteine (NAC), Annexin V-
FITC apoptosis detection kit, nitroblue tetrazolium salt (NBT) and
5P-bromo-4-chloro-3P-indolyl phosphate (BCIP) were procured from
Sigma Chemical Co., USA. Propidium iodide (PI) was purchased
from Calbiochem, DiOC6(3) from Molecular Probes and mouse anti-
cytochrome c monoclonal antibody (clone 7H8.2C12) was purchased
from Pharmingen.
2.2. Curcumin treatment
BC-8 cells (1U106) were plated in DMEM-FCS and treated with
50 WM curcumin. The cells were collected at di¡erent time points,
washed with PBS, ¢xed in 70% ethanol, stained with propidium iodide
(PI) and analyzed by £ow cytometry.
2.3. Comet assay
BC-8 cells (5U106 cells) were subjected to 50 WM curcumin treat-
ment for 4 h. The cells were washed, resuspended in 100 Wl of low
melting agarose (2%), maintained at 37‡C and layered on a frosted
slide. The slides were placed on ice (5 min) followed by treatment with
lysis bu¡er (150 mM NaCl, 10 mM Tris (pH 8), 10 mM EDTA, 0.5%
n-lauroyl sarcosine) for 5 min and distilled water (5 min). The slides
were subjected to electrophoresis in 0.03 M NaOH, 2 mM EDTA (5
min at 20 Volt). The cells were stained with PI and analyzed by a
£uorescent microscope [13].
2.4. Cytochrome c reduction
Superoxide induced reduction of ferricytochrome c to ferrocyto-
chrome c was monitored spectrophotometrically at 550 nm [14].
5U104 cells were suspended in complete phenol red-free DMEM
and plated in 96-well plates. The cells were treated with curcumin
(50 WM) and the time dependent superoxide anion release was esti-
mated in the presence of 80 WM cytochrome c with and without SOD
(300 U/ml).
In a parallel experiment NAC (1 mM) inhibitable cytochrome c
reduction was estimated after 1 h of curcumin treatment. The cellular
proteins were estimated with Bradford reagent using BSA as the
standard.
2.5. Release of cytochrome c from mitochondria
In order to monitor the release of mitochondrial cytochrome c to
the cytosol during curcumin mediated apoptosis, BC-8 cells (1U107)
treated with curcumin for 4 h, were washed in cold PBS, suspended in
0.5 ml ice-cold cytoplasmic extraction bu¡er (20 mM HEPES, pH 7.5,
10 mM KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 0.1 mM
phenylmethylsulfonyl£uoride and 1 mM DTT) and incubated on ice
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 9 6 9 - 2
*Corresponding author. Fax: +91 (40) 7171195.
E-mail: khar@ccmb.ap.nic.in
FEBS 22418 29-7-99
FEBS 22418 FEBS Letters 456 (1999) 311^314
for 30 min [15]. The cells were disrupted with 30 strokes in a dounce
homogenizer and centrifuged at 5000 rpm for 10 min at 4‡C. The
supernatant was further centrifuged at 100 000 rpm and frozen in
aliquots.
Cytoplasmic extracts were mixed with Laemmli’s sample bu¡er
containing L-mercaptoethanol and the proteins were separated on
12% SDS-polyacrylamide gel. The separated proteins were transferred
onto nitrocellulose membrane, blocked with blocking bu¡er (3% BSA,
0.02% Tween-20 in Tris bu¡er pH 7.5) at 4‡C. The blots were incu-
bated with anticytochrome c antibody diluted 1:1000 in blocking bu¡-
er for 3 h at room temperature. The bound antibody was detected
after washing and treatment with alkaline phosphatase linked anti-
mouse IgG and developed using BCIP substrate with NBT.
2.6. Annexin V staining
BC-8 cells (2U106) were cultured in DMEM-FCS and treated with
50 WM curcumin for 3 h. Control and treated BC-8 cells were sus-
pended in 80 Wl of binding bu¡er (100 mM HEPES/NaOH, pH 7.5,
containing 1.4 M NaCl and 25 mM CaCl2). Annexin V-FITC con-
jugate (5 ul) was added to each tube and incubated at room temper-
ature for 15 min. The cells were visualized by laser scanning confocal
microscopy [16].
2.7. Status of mitochondrial transmembrane potential
BC-8 cells were treated with curcumin under similar conditions at
37‡C. The v8m was estimated by staining cells with 50 nM DiOC6(3),
a cationic lipophilic dye [17] for 15 min at 37‡C. The dye accumulates
in actively respiring mitochondria depending on the membrane poten-
tial. The cells were washed with the culture media and visualized by
laser scanning confocal microscope at 488 nm.
3. Results
3.1. Curcumin mediated apoptosis
The e¡ect of curcumin on tumor cell apoptosis was moni-
tored at di¡erent time points by £ow cytometry (Table 1). The
initiation of apoptosis was observed as early as 1 h. There was
a progressive increase in pre-G0/G1 peak with time, which
comprised of the apoptotic cells. The cell death reached
84.5% by 4 h of curcumin treatment. Subsequently the cells
showed cytoplasmic blebbing, nuclear fragmentation and dis-
integration.
3.2. Curcumin induced DNA fragmentation
In contrast to the routine methods used to assess DNA
fragmentation like TUNEL assay or internucleosomal DNA
laddering which are assayed in a total cell population, we have
used the comet assay procedure to monitor DNA fragmenta-
tion at the single cell level [13]. The induction of apoptosis in
AK-5 cells led to the fragmentation of the cellular DNA that
migrated out of the cells during electrophoresis. The frag-
mented DNA formed a typical comet tail-like pattern after
staining with propidium iodide (Fig. 1B). The control BC-8
cells, with intact DNA do not show this pattern (Fig. 1A).
3.3. Release of superoxide anion
Treatment of BC-8 cells with curcumin resulted in a £ush of
superoxide release in the extracellular milieu within 20 min as
noted by the reduction of ferricytochrome c to ferrocyto-
chrome c by superoxide anion. The O32 release was initiated
within 15 min and reached the peak at 1 h time point followed
by progressive decrease. The speci¢city of the reduction was
controlled by its inhibition by SOD (Fig. 2A). In addition, the
superoxide production was inhibited by antioxidants like N-
acetyl-L-cysteine (Fig. 2B), thus con¢rming that superoxide
anion is regulating the downstream events of apoptosis. The
BC-8 cells did not show superoxide release under normal con-
ditions.
3.4. Change in membrane asymmetry
The hydrophobic property of curcumin enabled the mole-
cule to pass through the plasma membrane and accumulate on
the nuclear envelope and ER, depicting bright auto£uores-
cence (Fig. 3A). Curcumin treatment resulted in the exposure
of phosphatidylserine (PS) residues, which normally reside on
the inner membrane, to the outer membrane lea£et on the
treated cells. We analyzed the PS exposure by confocal mi-
Fig. 1. Induction of DNA fragmentation after treatment of AK-5
cells with curcumin and formation of comet tail after electrophore-
sis. A: control; B: curcumin treated cells.
Fig. 2. Generation of extracellular superoxide anion by BC-8 cells
after treatment with 50 WM curcumin. A: SOD inhibitable cyto-
chrome c reduction at di¡erent time points; mean þ S.D. B: NAC
inhibitable superoxide generation as detected after 1 h of curcumin
treatment. 1, control cells; 2, curcumin treated positive control;
3, curcumin and NAC treated cells.
Table 1
Curcumin induced apoptosis in AK-5 cellsa
Time (hr) Apoptotic cells (%)
Control 1.00




aAK-5 tumor cells (1U106) treated with curcumin (50 WM) were
collected at di¡erent time points, ¢xed, stained with PI and ana-
lyzed by £ow cytometry. The apoptotic cells represent pre-G0/G1
peak.
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croscopy using Annexin V-FITC conjugate. Annexin binds to
the negatively charged phosphatidylserine exposed on the cel-
lular membrane and the conjugated FITC showed a ring-like
stain along the cellular boundary (Fig. 3C). The control BC-8
cells did not show any such staining pattern (Fig. 3A). PS
externalization is an early marker for apoptotic induction,
that may allow cells to be recognized by macrophages [18,19].
3.5. Loss of mitochondrial membrane potential
In order to study the mechanism of ROI mediated apopto-
sis by curcumin in BC-8 cells, we also studied the e¡ect on the
cellular mitochondrial transmembrane potential. The uptake
of mitochondrial membrane potential sensitive dye, DiOC6(3)
was visualized by confocal microscopy (Fig. 3D). The mito-
chondrial membrane potential was lost after 2^4 h of treat-
ment of cells with curcumin (Fig. 3E) prior to the visualiza-
tion of the apoptotic features in these cells, whereas normal
cells retained the membrane potential and were brightly £uo-
rescent.
3.6. Analysis of mitochondrial cytochrome c
The release of mitochondrial cytochrome c to the cytosol,
and the initiation of a cascade of proteolytic events in the
cytosol subsequent to cytochrome c release has been docu-
mented earlier [20]. The superoxide anion release and reduc-
tion in mitochondrial membrane potential in BC-8 cells was
followed by release of cytochrome c to the cytosol after 3 h of
treatment with curcumin. The accumulation of cytochrome c
in the cytosol of curcumin treated cells was con¢rmed by
Western blot analysis.
4. Discussion
In the present investigation we have studied the mechanism
of curcumin mediated apoptotic death in AK-5 tumor cells.
This polyphenolic, hydrophobic compound, can di¡use easily
into the cytosol, triggering speci¢c apoptotic events. We have
implicated the involvement of ROS in curcumin mediated
apoptosis in AK-5 cells earlier [11]. ROS includes free radicals
such as superoxide (O32 ), hydroxyl radicals (
cOH) and non-
radical derivatives of oxygen like H2O2. They cause damage in
most of the biomolecules including DNA, protein, lipid mem-
brane etc. [21]. Superoxide may also react with nitric oxide to
yield peroxynitrite, a more powerful and damaging oxidant
than either of the two [22]. Thus ROS could play an impor-
tant role in the antitumor events leading to apoptotic tumor
cell death [23]. Curcumin induced alterations in membrane
dynamics have been observed recently [24].
Due to its unique physicochemical property curcumin
passes easily through the plasma membrane (Fig. 3A) and
evokes membrane perturbation by a¡ecting the membrane
lipid bilayer. Closer study by Jaruga et al. [24] on curcumin
treated erythrocytes showed possibility of membrane lipid re-
arrangement leading to transient exposure of phosphatidylser-
ine. Similar events of PS exposure in AK-5 cell membrane
were observed after curcumin treatment (Fig. 3C). We have
also quantitated simultaneous hyperproduction of superoxide
anion in the extracellular milieu during the ¢rst hour of cur-
cumin treatment (Fig. 2). The correlation between superoxide
hypergeneration and PS exposure was also observed by Hirsch
et al. during apoptotic events [25]. Curcumin may cause struc-
Fig. 3. E¡ect of curcumin on AK-5 membrane asymmetry and changes in mitochondrial transmembrane potential. A: accumulation of curcu-
min in AK-5 cells; B: phase contrast picture of AK-5 cells treated with curcumin; C: cells treated with 50 WM curcumin and stained with An-
nexin V-FITC showing the cell membrane as a ring, indicating exposure of PS on the outer plasma membrane; D: control cells treated with
membrane potential sensitive dye DiOC6(3); and E: cells treated with curcumin for 4 h and stained with DiOC6(3).
Fig. 4. Cytochrome c release from the AK-5 cell mitochondria after
treatment with curcumin. Lane 1, molecular weight markers; lane 2,
AK-5 (control); lane 3, curcumin treated AK-5 cells.
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tural and functional changes in cellular membrane integrity
leading to the £ipping of PS to the outer cell surface which
participates in the free radical release. Superoxide anions are
reported to penetrate the cell membrane through anion chan-
nels [26]. Such extracellular ROS may also di¡use non-specif-
ically into the cells causing direct damage to various bio-
molecules [27].
NADPH oxidase and xanthine oxidase, endoplasmic retic-
ulum, peroxisome and mitochondrial electron transport chain
(ETC) are some potential sources of superoxide generation in
cells [22]. Superoxide generating membrane bound NADPH
oxidase requires the presence of PS as an e¡ector molecule
[28]. Inhibition of NADPH oxidase by diphenyliodinium has
been reported to protect HL-60 cells from apoptosis, when
treated with H2O2, UV or actinomycin D [29]. Tsang et al.
have reported cOH mediated induction of internucleosomal
DNA fragmentation [30]. To determine the initiation of apop-
totic events, curcumin treated AK-5 cells were monitored by
£ow cytometry. The release of superoxide anion within the
¢rst hour of curcumin treatment initiated cell death (Table
1). The cells underwent complete DNA fragmentation within
6^8 h of treatment (data not shown).
The apoptotic events in AK-5 cells were controlled by the
antioxidant NAC, proving its redox sensitivity. The treatment
of cells with curcumin led to the activation of caspase-3-like
proteases which trigger the downstream cascade of apoptotic
events [14]. Similar ROS mediated apoptotic events have been
documented earlier [25]. We also observed the release of cy-
tochrome c in the cytosol (Fig. 4). Overexpression of Bcl-2, an
integral mitochondrial membrane protein blocked cytochrome
c release [15,31], thereby inhibiting release of apoptogenic
proteases possibly by binding to cytochrome c [32].
We have also observed loss of the mitochondrial transmem-
brane potential, prior to the visualization of the apoptotic
events in AK-5 cells, treated with curcumin (Fig. 3E). Such
loss of mitochondrial membrane potential has been correlated
to the induction of apoptosis via caspases. Mitochondrial de-
polarization is associated with the permeability transition
(PT). Induction of PT leads to liberation of apoptogenic pro-
teins like AIF (apoptosis inducing factor) and cytochrome c,
which in turn activate caspase-3-like proteases and show
apoptosis associated changes in cellular redox potential [33].
Nitric oxide, another well known short lived free radical has
been recently identi¢ed to be a potent inhibitor of apoptosis
[34]. This radical is produced by NOS isoforms and is capable
of inhibiting caspase-3 activity. Nitric oxide mediated suppres-
sion of apoptosis is also associated with inhibition of Bcl-2
cleavage and cytochrome c release [35]. Curcumin treated AK-
5 cells did not release NO and there was no expression of
iNOS seen in these cells (data not shown). Therefore it seems
that the AK-5 cells have preferentially chosen ROS mediated
apoptotic pathway on treatment with curcumin.
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